| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/09/2006 | WO2006025307A1 Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition |
| 03/09/2006 | WO2006025286A1 Constitutional function-improving agents |
| 03/09/2006 | WO2006024770A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/09/2006 | WO2006024390A1 Hexahydro-pyrazino[1,2-a]pyrimidine-4, 7-dione derivatives substituted with amino acids |
| 03/09/2006 | US20060052458 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| 03/09/2006 | US20060052455 Composition for preventing treating the xepression of clinical symptom in disease caused by mitochondrial dysfunction |
| 03/09/2006 | US20060052440 Medicinal composition for treating sudden deafness |
| 03/09/2006 | US20060052435 Selective dopamin d3 receptor agonists for the treatment of sexual dysfunction |
| 03/09/2006 | US20060052419 Use of pyridly amides as inhibitors of angiogenesis |
| 03/09/2006 | US20060052415 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052403 Novel adenine compound and use thereof |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052389 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/09/2006 | US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 03/09/2006 | US20060052381 Solubilized topoisomerase poisons |
| 03/09/2006 | US20060052379 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 03/09/2006 | US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 03/09/2006 | US20060052368 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
| 03/09/2006 | US20060052367 Remedy for glaucoma comprising rho kinase inhibitor and beta-blocker |
| 03/09/2006 | US20060052362 Skeletal muscle protecting agent |
| 03/09/2006 | US20060052361 Aids therapy; side effect reduction |
| 03/09/2006 | US20060052333 Method of treating arrhythmias |
| 03/09/2006 | US20060052332 1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-carboxamides; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052318 Tyrosinase activity cntrolling agent, process for producing the same and external preparations containing the same |
| 03/09/2006 | US20060052317 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 03/09/2006 | US20060052313 Selective dipeptide inhibitors of kallikrein |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060052294 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 03/09/2006 | US20060052293 For therapy of obesity, hypertriglyceridemia, diet-induced insulin resistance, and/or type 2 diabetes |
| 03/09/2006 | US20060052285 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051867 Cell growth |
| 03/09/2006 | US20060051842 Nucleic acid encoding alpha chain of human IL-11 receptor |
| 03/09/2006 | US20060051754 Transporter selectively transporting sulfate conjugate and its gene |
| 03/09/2006 | US20060051439 comprises acerola seed extract containing quercitrin |
| 03/09/2006 | US20060051438 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 03/09/2006 | US20060051433 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 03/09/2006 | US20060051425 Method of microencapsulation |
| 03/09/2006 | US20060051376 Remedy for fibromyalgia |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051343 Preventives remedies for bone and joint diseases |
| 03/09/2006 | US20060051316 Remedy |
| 03/09/2006 | US20060051295 Estrogen receptor interaction with a transcription factor |
| 03/09/2006 | US20060051293 noninvasive technique for imaging and quantitating amyloid deposits; 2-phenyl- imidazo [1,2,a] pyridine derivatives; radiolabelling; drug delivery; 2-(4'-dimethylaminophenyl)-6-iodobenzothiazole |
| 03/09/2006 | US20060051292 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 03/09/2006 | CA2578780A1 Hexahydro-pyrazino[1,2-a]pyrimidine-4, 7-dione derivatives substituted with amino acids |
| 03/09/2006 | CA2578604A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | CA2578552A1 Medicinal composition for percutaneous perospirone administration |
| 03/09/2006 | CA2577964A1 Ligands for g-protein coupled receptors |
| 03/09/2006 | CA2577947A1 Novel substituted imidazole derivative |
| 03/09/2006 | CA2577928A1 Molecular chaperone function regulator |
| 03/09/2006 | CA2577451A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b and other therapeutic proteins |
| 03/09/2006 | CA2576827A1 Vegf inhibition |
| 03/09/2006 | CA2576781A1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/08/2006 | EP1632492A1 Tricyclic compound |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction |
| 03/08/2006 | EP1632235A2 Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders |
| 03/08/2006 | EP1632234A2 (S,S)-reboxetine for treating chronic fatigue syndrome |
| 03/08/2006 | EP1632224A1 Spill resistant pharmaceutical compositions |
| 03/08/2006 | EP1631310A1 Cells used as carriers for bacteria |
| 03/08/2006 | EP1631299A2 Methods and compositions to treat myocardial conditions |
| 03/08/2006 | EP1631265A2 Use of various agents for inhibiting fibrous adhesions |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1448592B1 Steroidal compounds for inhibiting steroid sulphatase |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1445252B1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 03/08/2006 | EP1429689A4 Rational drug therapy device and methods |
| 03/08/2006 | EP1423407B1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 03/08/2006 | EP1406628B1 Tetrahydroquinoline derivatives |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1390371B1 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 03/08/2006 | EP1387841B1 Novel azole or triazole derivatives, method for preparing the same and use thereof as fungicides |
| 03/08/2006 | EP1385821A4 Novel anti-adhesive compounds and uses thereof |
| 03/08/2006 | EP1365761B1 Therapeutic combination of amlodipine and benazepril |
| 03/08/2006 | EP1353926B1 Mikanolide derivatives, their preparation and therapeutic uses |
| 03/08/2006 | EP1349853B1 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents |
| 03/08/2006 | EP1326585B1 Method for producing powdery formulations |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1276722B1 Naphthamidine urokinase inhibitors |
| 03/08/2006 | EP1276503B1 Screening methods for inhibitors of an acrab and an acrab-like efflux pump |
| 03/08/2006 | EP1244670B1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 03/08/2006 | EP1223913B1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 03/08/2006 | EP1206261B1 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 03/08/2006 | EP1204744B1 Isolated peptide of the horny layer and use thereof |
| 03/08/2006 | EP1178967B1 Quinoline derivatives as inhibitors of mek enzymes |
| 03/08/2006 | EP1176959B1 Novel prolines as antimicrobial agents |
| 03/08/2006 | EP1102776B1 Water soluble prodrugs of hindered phenols |
| 03/08/2006 | EP1071430B1 Treatment of iatrogenic and age-related hypertension with vitamin b6 derivatives and pharmaceutical compositions useful therein |
| 03/08/2006 | EP1044186B1 Substituted 2-benzylamino-2-phenyl-acetamide compounds |